Buy Tavalisse from Europe also called Talvesse at over 55% discount.
Non-english packaging is often present for European medicines- English label and English insert included. Plan in advance - allow us 7 days to ship this brand name medicine.
According to the European Medicines Agency, brand name Talvesse originating from Europe is manufactured at the following site(s):Instituto Grifols, S.A.
Can Guasc, 2 - Parets del Vallès
08150 Barcelona - Spain
Information about Tavalisse (Fostamatinib)
Tavalisse is the brand name for fostamatinib, a medication that is used primarily to treat autoimmune diseases. It is an oral inhibitor of spleen tyrosine kinase (SYK), a protein involved in the activation of immune cells. By blocking SYK, Tavalisse helps modulate immune responses and reduce inflammation associated with certain conditions, particularly those involving abnormal platelet destruction.
Product Highlights
- Tavalisse is specifically indicated for the treatment of chronic ITP in adults who have not responded to other treatments like corticosteroids or immunoglobulins.
- Although primarily approved for ITP, fostamatinib may also be explored for other autoimmune or inflammatory conditions, though these are not FDA-approved uses.
Key Ingredient
Key Benefits
- By inhibiting SYK, Tavalisse helps prevent the destruction of platelets, thereby increasing platelet counts in patients with chronic ITP.
- Unlike steroids or other immunosuppressive therapies, Tavalisse provides an alternative treatment for ITP with a potentially lower risk of steroid-related side effects.
- Tavalisse offers the convenience of oral administration, which is easier for long-term management compared to intravenous treatments.
Direction of Use
- Tavalisse is typically taken orally in the form of tablets.
- The usual starting dose is 100 mg twice daily. Depending on the patient’s response and tolerance, the dosage can be adjusted.
- It is important to take Tavalisse exactly as prescribed by the healthcare provider. If a dose is missed, it should be taken as soon as remembered, but if it is almost time for the next dose, skip the missed dose—do not double up.
Safety Concerns
- Because Tavalisse modulates immune function, it may increase the risk of infections, including serious or opportunistic infections.
- Liver function should be monitored regularly, as fostamatinib can cause liver damage or elevation in liver enzymes.
- Tavalisse can cause high blood pressure, so blood pressure should be monitored during treatment.
- Patients taking Tavalisse may experience reductions in white blood cell counts, red blood cell counts, and platelets, so blood tests are important to monitor for any adverse effects.
Avoid Tavalisse (Fostamatinib) If
- Avoid use in patients with active liver disease or elevated liver enzymes, as fostamatinib may worsen liver function.
- Patients with uncontrolled hypertension should not take Tavalisse, as it can elevate blood pressure.
- Tavalisse is not recommended during pregnancy and breastfeeding due to potential harm to the fetus or infant.
- Do not use Tavalisse in patients with active or untreated infections, especially serious or opportunistic infections.
- Patients who are allergic to fostamatinib or any of its ingredients should avoid taking the medication.
